ABSTRACT
The ANTHEM (Advanced Technologies for Human-centered Medicine) Radio-Frequency Quadrupole (RFQ) will employ eight coaxial power couplers, which will be magnetically coupled to the device through a loop antenna. The coupler design can support up to 140 kW in continuous wave operation. This paper presents the design of the cavity used for high-power testing, with the primary objectives of both optimizing the coupling between the couplers and ensuring operations at the designated operating frequency. Furthermore, the paper encompasses thermal and structural assessments conducted through numerical simulations.
ABSTRACT
This paper addresses the design of beam position monitor (BPM) devices suitable for fourth-generation diffraction-limited X-ray storage rings. Detailed investigations of the electromagnetic (EM) phenomena occurring inside the component under various working conditions are carried out by considering different BPM EM models defined by their geometry and materials. Moving from a theoretical characterization of the common round geometry, rhomboidal structures are studied through a careful numerical analysis relying on advanced computer-aided tools. Several critical elements, such as wakefields, pick-up signal extraction, and trapped and propagating modes, are explored from the simulation point of view and from the experimental one, by deploying a manufactured microwave test bench, which is employed to measure the radio frequency behavior of a BPM prototype built at Elettra Sincrotrone Trieste. The aim of the proposed study is to identify a satisfactory tradeoff between achievable performance and practical realizability for BPM devices operating in last-generation light sources.
ABSTRACT
In many resonant structures the damping of parasitic or higher order modes is indispensable to guarantee a correct and stable performance. This is particularly true in the microwave region in case of cavities or other resonant systems operating in accelerating structures, where the mitigation of spurious resonance effects is mandatory to achieve high quality particle beams. We present the results on the mode suppression in a real pillbox cavity by inserting a properly designed pyramidal metamaterial that acts as light, small volume damper for specific resonances in the range 3-4 GHz, only slightly perturbing other intrinsic modes. Measurements of the cavity response without and with the metamaterial absorber are presented and compared with full wave simulations. Field distribution for the pillbox intrinsic modes under scrutiny is also presented, showing that damping induced by the metamaterial critically depends on its relative position inside the cavity.
ABSTRACT
BACKGROUND: The purpose of this study was to evaluate the performance of an insulin infusion protocol targeting a blood glucose (BG) level of 140-180 mg/dL and to characterize protocol adherence. MATERIALS AND METHODS: This was a retrospective observational cohort study including patients for whom the protocol was ordered from January 2012 to May 2013. Performance metrics were assessed in all patients and in patients with an initial BG level of ≥200 mg/dL. Protocol adherence was assessed in a random subset of 50 patients without hypoglycemia and in all hypoglycemic patients. RESULTS: In patients with an initial BG level of ≥200 mg/dL, the mean time to goal was 7.1 h. The rate of decline of BG level in the first 6 h was 16.4 mg/dL/h. Mean BG level was 167 mg/dL, with 43.9% of BG values within goal and 80.3% between 80 and 199 mg/dL. The rate of hypoglycemic events was 0.14 per 100 h. The mean protocol violation rate was higher in patients with hypoglycemia compared with those without (39.8 vs. 23.5 per 100 h, P = 0.002), and 60.7% of hypoglycemic events were attributable to protocol violations. The protocol violation rate (42.8 vs. 17.6 per 100 h; P < 0.001) and the odds of hypoglycemia (odds ratio = 5.2; 95% confidence interval, 1.6, 16.5) were higher in the cardiac surgery patients compared with other patients. CONCLUSIONS: This protocol provides adequate BG control within the clinically acceptable range of 80-199 mg/dL but not within the narrower range of 140-180 mg/dL, with a low incidence of hypoglycemia. Risk factors for hypoglycemia and barriers to protocol adherence in the cardiac surgery population should be elucidated.
